REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 93 filers reported holding REGULUS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $118,000 | -31.4% | 595,501 | +139.2% | 0.00% | – |
| Q2 2018 | $172,000 | +84.9% | 248,978 | +93.0% | 0.00% | – |
| Q1 2018 | $93,000 | -35.0% | 128,989 | -6.3% | 0.00% | – |
| Q4 2017 | $143,000 | +164.8% | 137,589 | +215.7% | 0.00% | – |
| Q3 2017 | $54,000 | -72.3% | 43,589 | -63.2% | 0.00% | – |
| Q1 2017 | $195,000 | -73.0% | 118,341 | -63.2% | 0.00% | -100.0% |
| Q4 2016 | $723,000 | -66.0% | 321,200 | -50.2% | 0.00% | -75.0% |
| Q3 2016 | $2,128,000 | +240.5% | 645,000 | +1031.6% | 0.00% | +300.0% |
| Q2 2015 | $625,000 | – | 57,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |